OpenCapital
Earnings
Stock Screener
Metrics
/
Stocks
Connect AI
Toggle navigation menu
Stocks
ALN
Alnylam Pharmaceuticals
Balance Sheet Statement
Accrued Contingent Liabilities
Current Liabilities
Accrued Contingent Liabilities
Export Chart
Analysis
Statement
Balance Sheet Statement
Section
Current Liabilities
First reported
Q4 2024
Last reported
Q4 2025
Apr 30, 2026
Metric ID:
accrued_contingent_liabilities
Historical Data
2 periods
Quarterly
Annual
Q4 '24
Q4 '25
Value
$0.00
$0.00
Range
$0.00 – $0.00
Accrued Contingent Liabilities at Other Companies
Moderna
MRNA
View metric
Frequently Asked Questions
What is Alnylam Pharmaceuticals's accrued contingent liabilities?
Alnylam Pharmaceuticals (ALNY) reported accrued contingent liabilities of $0.00 in Q4 2025.